Chattanooga Oncology Hematology Associates — Chattanooga, Tennessee

Chattanooga Oncology Hematology Associates is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Chattanooga Oncology Hematology Associates has participated in 55 clinical trials with 1 currently active.

Therapeutic areas: Kidney Cancer, Small Cell Lung Cancer, Carcinoma, Small Cell.

Sponsors: SCRI Development Innovations, LLC, Bristol-Myers Squibb, Celldex Therapeutics.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Chattanooga Oncology Hematology Associates?

Chattanooga Oncology Hematology Associates has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Chattanooga Oncology Hematology Associates conducted?

Chattanooga Oncology Hematology Associates has 55 clinical trials on record, with 1 currently active. Their work covers Kidney Cancer, Small Cell Lung Cancer, Carcinoma, Small Cell.

Is Chattanooga Oncology Hematology Associates accredited by Crixeo Health?

Chattanooga Oncology Hematology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Chattanooga Oncology Hematology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.